| pubmed-article:9086496 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9086496 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
| pubmed-article:9086496 | lifeskim:mentions | umls-concept:C0034826 | lld:lifeskim |
| pubmed-article:9086496 | lifeskim:mentions | umls-concept:C0206133 | lld:lifeskim |
| pubmed-article:9086496 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
| pubmed-article:9086496 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:9086496 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:9086496 | pubmed:dateCreated | 1997-6-23 | lld:pubmed |
| pubmed-article:9086496 | pubmed:abstractText | The in vitro effects of mercuric chloride (HgCl2) and methylmercury (CH3HgOH) on the M1 and M2 muscarinic receptor subtypes were investigated in rat brain cortical membranes. HgCl2 and CH3HgOH were almost equipotent in inhibiting the binding of [3H]telenzepine to M1 receptors (IC50s = 2.2 and 3.4 microM, respectively). Conversely, HgCl2 was a thirty-fold more potent inhibitor of [3H]AF-DX 384 binding to M2 sites than CH3HgOH (lC50s = 5 and 149 microM, respectively). In all cases HgCl2 showed steep and monophasic inhibition curves, whereas those of CH3HgOH were biphasic (M1) or shallow (M2). CH3HgOH-induced inhibition of both [3H]telenzepine and [3H]AF-DX 384 binding was of the competitive type, while HgCl2 caused a pronounced reduction of the Bmax value associated with a small change in affinity. CH3HgOH also decreased the affinity of the agonist carbachol for M1 and M2 receptors, while inorganic mercury had minimal effects on the carbachol dose-response curves. These results indicate that inorganic and organic mercury differ in their interaction with muscarinic receptor subtypes and that M1 receptors may represent a preferential target for their effects. | lld:pubmed |
| pubmed-article:9086496 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086496 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9086496 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086496 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9086496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086496 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9086496 | pubmed:issn | 0161-813X | lld:pubmed |
| pubmed-article:9086496 | pubmed:author | pubmed-author:ManziJJ | lld:pubmed |
| pubmed-article:9086496 | pubmed:author | pubmed-author:CostaPP | lld:pubmed |
| pubmed-article:9086496 | pubmed:author | pubmed-author:CostaL GLG | lld:pubmed |
| pubmed-article:9086496 | pubmed:author | pubmed-author:CanduraS MSM | lld:pubmed |
| pubmed-article:9086496 | pubmed:author | pubmed-author:CastoldiA FAF | lld:pubmed |
| pubmed-article:9086496 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9086496 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:9086496 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9086496 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9086496 | pubmed:pagination | 735-41 | lld:pubmed |
| pubmed-article:9086496 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:meshHeading | pubmed-meshheading:9086496-... | lld:pubmed |
| pubmed-article:9086496 | pubmed:articleTitle | Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. | lld:pubmed |
| pubmed-article:9086496 | pubmed:affiliation | Department of Environmental Health, University of Washington, Seattle 98195, USA. | lld:pubmed |
| pubmed-article:9086496 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9086496 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9086496 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086496 | lld:pubmed |
